← Back to all announcements
  • Dr. Mark Ormiston has been awarded a Tier 2 Canada Research Chair in Regenerative Cardiovascular Medicine. Congratulations!

    Published Wed Feb 10th 2016



    Dr. Ormiston (Biomedical and Molecular Sciences, Medicine and Surgery) studies cell-based therapies and cardiovascular immunology – the impact of immune cells on cardiovascular diseases. His research centers mostly on Pulmonary Arterial Hypertension. Taking elements of cardiovascular science, immunology and stem cell biology, he hopes to create new therapies and gain a greater understanding of disease processes. He is looking most forward to working alongside Dr. Stephen Archer and his fellow researchers in the Queen's CardioPulmonary Unit (Q-CPU)

    “For somebody doing my kind of work, working with a world leader like Stephen Archer and my colleagues here, having all of the equipment we have at our disposal, as well as a center that’s geared towards integrating science and patient-based activities, it was a perfect situation,” says Dr. Ormiston.


    http://www.queensu.ca/gazette/stories/supporting-cutting-edge-research?utm_source=e-queens-gazette_staff

    http://www.chairs-chaires.gc.ca/media-medias/lists-listes/2016/february-fevrier-eng.aspx